Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07533929) titled 'Incidence and Predictors of Elevated ALT in Postpartum CHB Mothers' on April 9.

Study Type: Observational

Primary Sponsor: The Third Affiliated Hospital of Guangzhou Medical University

Condition: Elevated Alanine Aminotransferase Postpartum Chronic Hepatitis B Mothers

Recruitment Status: Not recruiting

Date of First Enrollment: August 1, 2026

Target Sample Size: 352

To know more, visit https://clinicaltrials.gov/study/NCT07533929

Disclaimer: Curated by HT Syndication....